Drug factory · FDA FEI 3004186644
SGS Lab Simon
Vieux Chemin du Poete 10, Wavre (Bierges), Belgium
Problems found, fixed voluntarily at FDA's last inspection, Mar 10, 2025.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
5 drug inspections on record since 2012: 2 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| .alpha.1-Proteinase Inhibitor Human | Tests it | Takeda Pharmaceuticals America, Inc. | 0944-2884 |
| Apadamtase Alfa | Tests it | Takeda Pharmaceuticals America, Inc. | 64764-140, 64764-145 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Mar 10, 2025 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Mar 22, 2021 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Sep 27, 2017 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jun 6, 2014 | No problems found | Drug Quality Assurance | — |
| Jun 20, 2012 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis.